Primary Job Title Chief Development Officer Primary Organization 
KalVista Pharmaceuticals
Location Norton, Doncaster, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male Also Known As Christopher M. Yea, PhD
Chris holds a BSc and PhD in Biochemistry from the University of Bristol, UK. Following post-doctoral work, he spent several years at Roussel-UCLAF and Hoechst Marion Roussel before joining Ferring Pharmaceuticals. Chris led the Biology group and was responsible for transition of candidates into development. In 2008, Chris co-led the spin-out of
Vantia Ltd and most recently was Chief Operating Officer where he was responsible for development activities through Phase 3 trials.
In his position as Chief Development Officer, Chris is responsible for all development-related activities within KalVista Pharmaceuticals.
